Phase I trial of combination of antitumor immunotherapy targeted against cytomegalovirus (CMV) plus regulatory T-cell inhibition in patients with newly-diagnosed glioblastoma multiforme (GBM).

Phase I study of combination of antitumor immunotherapy targeted against cytomegalovirus (CMV) plus regulatory T-cell inhibition in patients with newly diagnosed glioblastoma multiforme (GBM).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e13030 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e13030-e13030

Author(s):

Gordana Vlahovic ◽

Gerald E. Archer ◽

Denise Lally-Goss ◽

Elizabeth Reap ◽

Annick Desjardins ◽

...

Keyword(s):

T Cell ◽

Glioblastoma Multiforme ◽

Phase I ◽

Regulatory T Cell ◽

Phase I Study ◽

Newly Diagnosed ◽

Antitumor Immunotherapy ◽

IT-34 * PILOT STUDY OF COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)

Neuro-Oncology ◽

10.1093/neuonc/nou258.32 ◽

2014 ◽

Vol 16 (suppl 5) ◽

pp. v117-v117 ◽

Cited By ~ 1

Author(s):

G. Vlahovic ◽

G. Archer ◽

D. Lally-Goss ◽

E. Reap ◽

K. Batich ◽

...

Keyword(s):

T Cell ◽

Pilot Study ◽

Glioblastoma Multiforme ◽

Regulatory T Cell ◽

Newly Diagnosed ◽

Antitumor Immunotherapy ◽

IMCT-19COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)

Neuro-Oncology ◽

10.1093/neuonc/nov218.19 ◽

2015 ◽

Vol 17 (suppl 5) ◽

pp. v111.4-v112

Author(s):

Gordana Vlahovic ◽

Gerald Archer ◽

Elizabeth Reap ◽

Ashley Ghiaseddin ◽

Annick Desjardins ◽

...

Keyword(s):

T Cell ◽

Glioblastoma Multiforme ◽

Regulatory T Cell ◽

Newly Diagnosed ◽

Antitumor Immunotherapy ◽

Regulatory T-cell inhibition plus antitumor immunotherapy targeted against cytomegalovirus (CMV) in patients with newly diagnosed glioblastoma multiforme (GBM).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.3069 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 3069-3069

Author(s):

Gordana Vlahovic ◽

Gerald E. Archer ◽

Denise Lally-Goss ◽

Sharon Norman ◽

Annick Desjardins ◽

...

Keyword(s):

T Cell ◽

Glioblastoma Multiforme ◽

Regulatory T Cell ◽

Newly Diagnosed ◽

Antitumor Immunotherapy ◽

NCOG-18. PHASE I TRIAL OF DIMETHYL FUMARATE, TEMOZOLOMIDE AND RADIATION THERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME: A PRELIMINARY NEUROCOGNITIVE PERSPECTIVE

Neuro-Oncology ◽

10.1093/neuonc/nox168.579 ◽

2017 ◽

Vol 19 (suppl_6) ◽

pp. vi141-vi142

Author(s):

Ashlee Loughan ◽

Danielle Shafer ◽

Autumn Lanoye ◽

Sarah Braun ◽

Paul Dent ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase I ◽

Phase I Trial ◽

Dimethyl Fumarate ◽

Newly Diagnosed ◽

Abstract C56: NCCTG phase I trial of everolimus (RAD001) and temozolomide (TMZ) in combination with radiation therapy (RT) in newly diagnosed glioblastoma multiforme (GBM) patients

10.1158/1535-7163.targ-09-c56 ◽

2009 ◽

Author(s):

Jann N. Sarkaria ◽

Evanthia Galanis ◽

Patrick Peller ◽

Paul Brown ◽

Wenting Wu ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase I ◽

Phase I Trial ◽

Newly Diagnosed ◽

Phase I Trial of Gross Total Resection, Permanent Iodine-125 Brachytherapy, and Hyperfractionated Radiotherapy for Newly Diagnosed Glioblastoma Multiforme

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2007.03.061 ◽

2007 ◽

Vol 69 (3) ◽

pp. 825-830 ◽

Cited By ~ 22

Author(s):

Allen M. Chen ◽

Susan Chang ◽

Jean Pouliot ◽

Penny K. Sneed ◽

Michael D. Prados ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase I ◽

Phase I Trial ◽

Gross Total Resection ◽

Newly Diagnosed ◽

Total Resection ◽

Hyperfractionated Radiotherapy ◽

Iodine 125

North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.05.064 ◽

2011 ◽

Vol 81 (2) ◽

pp. 468-475 ◽

Cited By ~ 52

Author(s):

Jann N. Sarkaria ◽

Evanthia Galanis ◽

Wenting Wu ◽

Patrick J. Peller ◽

Caterina Giannini ◽

...

Keyword(s):

Radiation Therapy ◽

Treatment Group ◽

Glioblastoma Multiforme ◽

Phase I ◽

Cancer Treatment ◽

Phase I Trial ◽

Newly Diagnosed ◽

North Central ◽

Phase I Trial of Hypofractionated Intensity-Modulated Radiotherapy With Temozolomide Chemotherapy for Patients With Newly Diagnosed Glioblastoma Multiforme

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.07.021 ◽

2011 ◽

Vol 81 (4) ◽

pp. 1066-1074 ◽

Cited By ~ 36

Author(s):

Changhu Chen ◽

Denise Damek ◽

Laurie E. Gaspar ◽

Allen Waziri ◽

Kevin Lillehei ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase I ◽

Phase I Trial ◽

Intensity Modulated Radiotherapy ◽

Newly Diagnosed ◽

Intensity Modulated ◽

Temozolomide Chemotherapy

Abstract 2654: GAPVAC-101 phase I trial: First data of an innovative actively personalized peptide vaccination trial in patients with newly diagnosed glioblastoma

10.1158/1538-7445.am2016-2654 ◽

2016 ◽

Cited By ~ 1

Author(s):

Norbert Hilf ◽

Katrin Frenzel ◽

Sabrina Kuttruff-Coqui ◽

Sandra Heesch ◽

Sebastian Kreiter ◽

...

Keyword(s):

Phase I ◽

Phase I Trial ◽

Newly Diagnosed ◽

Peptide Vaccination ◽

Vaccination Trial ◽